The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations

MOLECULAR CANCER THERAPEUTICS(2023)

引用 1|浏览7
暂无评分
关键词
selective met inhibitor,tepotinib—a,tumors harboring,preclinical pharmacology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要